GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » Capex-to-Revenue

Quantum-Si (Quantum-Si) Capex-to-Revenue : -0.92 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Quantum-Si's Capital Expenditure for the three months ended in Dec. 2023 was $0.37 Mil. Its Revenue for the three months ended in Dec. 2023 was $0.40 Mil.

Hence, Quantum-Si's Capex-to-Revenue for the three months ended in Dec. 2023 was -0.92.


Quantum-Si Capex-to-Revenue Historical Data

The historical data trend for Quantum-Si's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si Capex-to-Revenue Chart

Quantum-Si Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
- - - - 4.87

Quantum-Si Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.63 3.91 6.18 -0.92

Competitive Comparison of Quantum-Si's Capex-to-Revenue

For the Biotechnology subindustry, Quantum-Si's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum-Si's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum-Si's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Quantum-Si's Capex-to-Revenue falls into.



Quantum-Si Capex-to-Revenue Calculation

Quantum-Si's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-5.273) / 1.082
=4.87

Quantum-Si's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0.367) / 0.4
=-0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quantum-Si  (NAS:QSI) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Quantum-Si Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Quantum-Si's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum-Si (Quantum-Si) Business Description

Traded in Other Exchanges
N/A
Address
530 Old Whitfield Street, Guilford, CT, USA
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Executives
Amir Jafri director C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jeffry R. Keyes officer: Chief Financial Officer 13950 STOWE DRIVE, POWAY CA 92064-8803
Scott Mendel director 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Christian Lapointe officer: General Counsel & Corp. Secr. C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Grace Johnston officer: Chief Commercial Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Kevin Rakin director, officer: Chairman and CEO 36 CHURCH LANE, WESTPORT CT 06880
Jeffrey Alan Hawkins director, officer: Chief Executive Officer 5964 LA PLACE COURT, CARLSBAD CA 92008
Vikram Bajaj director 600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg director, 10 percent owner C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer officer: Chief Business Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna officer: President and COO C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider officer: President and COO C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark director, officer: Chief Executive Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc 10 percent owner C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437